Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Assessing AbbVie: Insights From 17 Financial Analysts
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
8 Health Care Stocks Whale Activity In Today's Session
Moderna Analyst Ratings
Neurocrine Biosciences Analyst Ratings
AbbVie Analyst Ratings
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Benzinga Market Summary: Bitcoin Falls, Vaccine Stocks Rise On Bird Flu Concerns, NVIDIA Drops
Shares of Vaccine Makers Are Trading Higher After the First Bird Flu Death Was Reporting in the US. Additionally, a Recent DCD Report Noted an Increase in Acute Respiratory Illness Activity.
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Spotlight on Moderna: Analyzing the Surge in Options Activity
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today